MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-28, QDEL made $2,730,200K in revenue. -$1,131,800K in net income. Net profit margin of -41.45%.

Income Overview

Revenue
$2,730,200K
Net Income
-$1,131,800K
Net Profit Margin
-41.45%
EPS
-$16.69
Unit: Thousand (K) dollars
Revenue Breakdown
    • Labs
    • Point Of Care
    • Immunohematology
    • Others
Revenue Breakdown
    • North America Segment
    • EMEASegment
    • China Segment
    • Others
Revenue Breakdown
    • Domestic Country
    • Foreign Country

Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Income Statement
2025-12-28
2024-12-29
Total revenues
2,730,200 2,782,900
Cost of sales, excluding amortization of intangibles
1,456,000 1,496,400
Selling, marketing and administrative
746,300 766,800
Acquisition and integration costs
-127,200
Research and development
186,200 218,700
Amortization of intangible assets
189,200 203,400
Restructuring, integration and other charges
263,600 -
Goodwill impairment charge
700,700 1,822,600
Asset impairment charge
9,700 56,900
Other operating expenses
97,700 51,800
Operating (loss) income
-919,200 -1,960,900
Interest expense, net
177,600 163,500
Loss on extinguishment of debt
-5,100 -
Other expense, net
-5,800 -7,100
Loss before income taxes
-1,107,700 -2,131,500
Provision for (benefit from) income taxes
24,100 -79,500
Net loss
-1,131,800 -2,052,000
Basic loss per share
-16.69 -30.54
Diluted loss per share
-16.69 -30.54
Weighted-average shares outstanding - basic
67,800,000 67,200,000
Weighted-average shares outstanding - diluted
67,800,000 67,200,000
Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Net loss-$1,131,800K Provision for (benefitfrom) income taxes$24,100K Loss before incometaxes-$1,107,700K Molecular Diagnostics$26,500K Point Of Care$601,600K Donor Screening$52,600K Immunohematology$543,800K Labs$1,505,700K Other expense, net-$5,800K Loss onextinguishment of debt-$5,100K Interest expense, net$177,600K Operating (loss) income-$919,200K Total revenues$2,730,200K Other operatingexpenses$97,700K Asset impairmentcharge$9,700K Goodwill impairmentcharge$700,700K Restructuring, integration andother charges$263,600K Amortization of intangibleassets$189,200K Research and development$186,200K Selling, marketing andadministrative$746,300K Cost of sales,excluding amortization of...$1,456,000K

QuidelOrtho Corp (QDEL)

QuidelOrtho Corp (QDEL)